Cargando…

Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study

BACKGROUND: Persons with bronchiectasis have a high risk of community-acquired pneumonia. Social distancing measures, implemented to prevent the spreading of SARS-CoV-2, could potentially reduce the incidence of other infectious diseases. RESEARCH QUESTION: Was the COVID-19 lockdown period, along wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rømer, Valdemar, Fosgaard, Martina Bjørka, Sivapalan, Pradeesh, Eklöf, Josefin, Saeed, Mohamad Isam, Toennesen, Louise Lindhardt, Svorre Jordan, Alexander, Gissel, Tina, Johansson, Sofie Lock, Jensen, Jens-Ulrik Stæhr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685970/
https://www.ncbi.nlm.nih.gov/pubmed/38016706
http://dx.doi.org/10.1136/bmjresp-2022-001517
_version_ 1785151724631097344
author Rømer, Valdemar
Fosgaard, Martina Bjørka
Sivapalan, Pradeesh
Eklöf, Josefin
Saeed, Mohamad Isam
Toennesen, Louise Lindhardt
Svorre Jordan, Alexander
Gissel, Tina
Johansson, Sofie Lock
Jensen, Jens-Ulrik Stæhr
author_facet Rømer, Valdemar
Fosgaard, Martina Bjørka
Sivapalan, Pradeesh
Eklöf, Josefin
Saeed, Mohamad Isam
Toennesen, Louise Lindhardt
Svorre Jordan, Alexander
Gissel, Tina
Johansson, Sofie Lock
Jensen, Jens-Ulrik Stæhr
author_sort Rømer, Valdemar
collection PubMed
description BACKGROUND: Persons with bronchiectasis have a high risk of community-acquired pneumonia. Social distancing measures, implemented to prevent the spreading of SARS-CoV-2, could potentially reduce the incidence of other infectious diseases. RESEARCH QUESTION: Was the COVID-19 lockdown period, along with accompanying social distancing measures, associated with reduced hospital admissions for community-acquired pneumonia and decreased overall mortality rates among individuals with bronchiectasis? METHODS: Social distancing measures were introduced in Denmark by 12 March 2020 and were preserved until 20 May 2020 (social distancing period), after which the measures were gradually dismissed. The study included all adults (≥18 years) with bronchiectasis residing in Denmark. Confirmed cases of SARS-CoV-2 infection were excluded. We retrospectively investigated the incidence of community-acquired pneumonia hospital admission, death of all causes and respiratory antibiotic treatment in the 10-week social distancing period in 2020, compared with the same dates in 2019. 9344 persons were included in the study. RESULTS: In the social distancing period, the incidence rate of pneumonia-hospitalisation per 10 000 person-weeks was 9.2 compared with 13.8 in the reference period. This reduction corresponds to an incidence rate ratio (IRR) of 0.67 (95% CI 0.51 to 0.88, p<0.01). Mortality was unchanged (IRR 0.90, 95% CI 0.61 to 1.32, p=0.58). Fewer persons received respiratory antibiotics (IRR 0.85, 95% CI 0.78 to 0.94, p<0.001). CONCLUSION: The social distancing period was associated with a lower incidence of community-acquired pneumonia hospitalisations and respiratory antibiotic treatments in persons with bronchiectasis while all-cause mortality remained unchanged.
format Online
Article
Text
id pubmed-10685970
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-106859702023-11-30 Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study Rømer, Valdemar Fosgaard, Martina Bjørka Sivapalan, Pradeesh Eklöf, Josefin Saeed, Mohamad Isam Toennesen, Louise Lindhardt Svorre Jordan, Alexander Gissel, Tina Johansson, Sofie Lock Jensen, Jens-Ulrik Stæhr BMJ Open Respir Res Bronchiectasis BACKGROUND: Persons with bronchiectasis have a high risk of community-acquired pneumonia. Social distancing measures, implemented to prevent the spreading of SARS-CoV-2, could potentially reduce the incidence of other infectious diseases. RESEARCH QUESTION: Was the COVID-19 lockdown period, along with accompanying social distancing measures, associated with reduced hospital admissions for community-acquired pneumonia and decreased overall mortality rates among individuals with bronchiectasis? METHODS: Social distancing measures were introduced in Denmark by 12 March 2020 and were preserved until 20 May 2020 (social distancing period), after which the measures were gradually dismissed. The study included all adults (≥18 years) with bronchiectasis residing in Denmark. Confirmed cases of SARS-CoV-2 infection were excluded. We retrospectively investigated the incidence of community-acquired pneumonia hospital admission, death of all causes and respiratory antibiotic treatment in the 10-week social distancing period in 2020, compared with the same dates in 2019. 9344 persons were included in the study. RESULTS: In the social distancing period, the incidence rate of pneumonia-hospitalisation per 10 000 person-weeks was 9.2 compared with 13.8 in the reference period. This reduction corresponds to an incidence rate ratio (IRR) of 0.67 (95% CI 0.51 to 0.88, p<0.01). Mortality was unchanged (IRR 0.90, 95% CI 0.61 to 1.32, p=0.58). Fewer persons received respiratory antibiotics (IRR 0.85, 95% CI 0.78 to 0.94, p<0.001). CONCLUSION: The social distancing period was associated with a lower incidence of community-acquired pneumonia hospitalisations and respiratory antibiotic treatments in persons with bronchiectasis while all-cause mortality remained unchanged. BMJ Publishing Group 2023-11-27 /pmc/articles/PMC10685970/ /pubmed/38016706 http://dx.doi.org/10.1136/bmjresp-2022-001517 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Bronchiectasis
Rømer, Valdemar
Fosgaard, Martina Bjørka
Sivapalan, Pradeesh
Eklöf, Josefin
Saeed, Mohamad Isam
Toennesen, Louise Lindhardt
Svorre Jordan, Alexander
Gissel, Tina
Johansson, Sofie Lock
Jensen, Jens-Ulrik Stæhr
Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study
title Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study
title_full Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study
title_fullStr Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study
title_full_unstemmed Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study
title_short Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study
title_sort incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the covid-19 lockdown in denmark: a retrospective cohort study
topic Bronchiectasis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685970/
https://www.ncbi.nlm.nih.gov/pubmed/38016706
http://dx.doi.org/10.1136/bmjresp-2022-001517
work_keys_str_mv AT rømervaldemar incidenceofcommunityacquiredpneumoniahospitalisationinpersonswithbronchiectasisduringthecovid19lockdownindenmarkaretrospectivecohortstudy
AT fosgaardmartinabjørka incidenceofcommunityacquiredpneumoniahospitalisationinpersonswithbronchiectasisduringthecovid19lockdownindenmarkaretrospectivecohortstudy
AT sivapalanpradeesh incidenceofcommunityacquiredpneumoniahospitalisationinpersonswithbronchiectasisduringthecovid19lockdownindenmarkaretrospectivecohortstudy
AT eklofjosefin incidenceofcommunityacquiredpneumoniahospitalisationinpersonswithbronchiectasisduringthecovid19lockdownindenmarkaretrospectivecohortstudy
AT saeedmohamadisam incidenceofcommunityacquiredpneumoniahospitalisationinpersonswithbronchiectasisduringthecovid19lockdownindenmarkaretrospectivecohortstudy
AT toennesenlouiselindhardt incidenceofcommunityacquiredpneumoniahospitalisationinpersonswithbronchiectasisduringthecovid19lockdownindenmarkaretrospectivecohortstudy
AT svorrejordanalexander incidenceofcommunityacquiredpneumoniahospitalisationinpersonswithbronchiectasisduringthecovid19lockdownindenmarkaretrospectivecohortstudy
AT gisseltina incidenceofcommunityacquiredpneumoniahospitalisationinpersonswithbronchiectasisduringthecovid19lockdownindenmarkaretrospectivecohortstudy
AT johanssonsofielock incidenceofcommunityacquiredpneumoniahospitalisationinpersonswithbronchiectasisduringthecovid19lockdownindenmarkaretrospectivecohortstudy
AT jensenjensulrikstæhr incidenceofcommunityacquiredpneumoniahospitalisationinpersonswithbronchiectasisduringthecovid19lockdownindenmarkaretrospectivecohortstudy